ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery

ClinicalTrials.gov ID: NCT05754333

Public ClinicalTrials.gov record NCT05754333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Prospective, Randomized, Open-label Study for Intraoperative Ureter(s) Visualization When Using ASP5354 With Near Infrared Fluorescence (NIR-F) Imaging in Participants Undergoing Minimally Invasive and Open Abdominopelvic Surgeries

Study identification

NCT ID
NCT05754333
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
107 participants

Conditions and interventions

Interventions

  • pudexacianinium chloride Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2023
Primary completion
Dec 16, 2024
Completion
Jan 15, 2025
Last update posted
Oct 8, 2025

2023 – 2025

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
AdventHealth Orlando Orlando Florida 32803
Advent Health Tampa Tampa Florida 33613
Cleveland Clinic Florida Weston Florida 33331
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Icahn School of Medicine at Mount Sinai New York New York 10029
M.D. Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05754333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05754333 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →